ENDOWMENT CASE FUNDING | 1
The MRF is leading the charge in changing the research landscape from bench to bedside, investing in melanoma patients and their families’ future. There are now 16 FDA-approved single and combination treatments to fight melanoma resulting in over 50% of metastatic patients having no evidence of disease. However, melanoma diagnosis rates have continued to rise rapidly over the past few decades. In 2021 alone over 106,000 will be diagnosed. On average, there has been a year-over-year increase of 2%.
16 FDA-APPROVED TREATMENTS
Increase IN MELANOMA DIAGNOSIS RATES
FDA TIMELINE
1998
FDA approves the first immunotherapy for metastatic melanoma.
Made with FlippingBook Ebook Creator